Search

Your search keyword '"Karamchandani DM"' showing total 52 results

Search Constraints

Start Over You searched for: Author "Karamchandani DM" Remove constraint Author: "Karamchandani DM"
52 results on '"Karamchandani DM"'

Search Results

1. Spectra of well-differentiated neuroendocrine lesions in the extrahepatic biliary system: a case series.

2. Unravelling interobserver variability in gastrointestinal glandular neoplasia: a contemporary study of US and Korean pathologists.

Catalog

Books, media, physical & digital resources

3. PD-L1 (22C3) expression and prognostic implications in esophageal squamous cell carcinoma.

4. Utility of IMP3, p53, and S100P immunohistochemical stains in distinguishing reactive atypia from dysplasia in cholecystectomy specimens.

5. INSM1 is a useful neuroendocrine marker to differentiate pancreatic serous cystadenoma from pancreatic well-differentiated neuroendocrine tumors in cytology and surgical specimens.

6. Follow-up biopsies in gastrointestinal immune checkpoint inhibitor toxicity may show markedly different inflammatory patterns than initial injury.

7. Debating Deposits, Redux: Substantial Interobserver Agreement Exists in Distinguishing Tumor Deposits From Nodal Metastases in Small Bowel Neuroendocrine Tumors.

8. Macroscopic examination of pathology specimens: a critical reappraisal.

9. Essentials of macroscopic evaluation of specimens from gastrointestinal tract.

10. Histopathologic Manifestations of Immune Checkpoint Inhibitor Therapy-Associated Gastrointestinal Tract Injury: A Practical Review.

11. Pax8 as a useful adjunct marker to differentiate pancreatic serous cystadenoma from clear cell renal cell carcinoma in both cytologic and surgical specimens.

12. Practice patterns for reporting digestive system neuroendocrine neoplasms: results from a large, comprehensive international survey.

13. Drug-induced digestive tract injury: decoding some invisible offenders.

15. Sinusoidal Growth Pattern of Hepatic Melanoma Metastasis: Implications for Histopathologic Diagnosis.

16. Interobserver Variability in Assessment of Depth of Submucosal Invasion for Colonic Endoscopic Resections Among Subspecialized Gastrointestinal Pathologists.

17. Lack of uniformity in reporting autoimmune gastritis among a diverse group of pathologists.

18. Oesophageal post-therapy myeloid sarcoma masquerading as poorly differentiated adenocarcinoma: a diagnostic pitfall.

19. Fibrocystic Changes of the Breast: Radiologic-Pathologic Correlation of MRI.

20. Measuring depth of invasion of submucosa - invasive adenocarcinoma in oesophageal endoscopic specimens: how good are we?

21. New Kids on the Block.

22. Erythropoietic protoporphyria- associated hepatopathy: expanding the spectra of brown pigments encountered in hepatic specimens.

23. T3 versus T4a staging challenges in deeply invasive colonic adenocarcinomas and correlation with clinical outcomes.

24. Splenic-vasculature involvement is associated with poor prognosis in resected distal pancreatic cancer.

25. Yttrium-90 Microsphere Selective Internal Radiation Therapy-Induced Cholecystitis.

26. Lymphocytic colitis pattern of injury presenting as endoscopic polyps: a case series.

27. The mRNA-binding protein IGF2BP1 maintains intestinal barrier function by up-regulating occludin expression.

28. Validation of American Joint Committee on Cancer 8 th edition of TNM staging in resected distal pancreatic cancer.

29. Incidence of Post-Liver Transplant Hepatic Dysfunction After Sustained Virologic Response Following Direct-Acting Anti-Hepatitis C Therapy.

30. Clinicopathologic features of Buschke-Löwenstein tumor: a multi-institutional analysis of 38 cases.

31. Complete histopathologic examination of risk reduction gastrectomy specimens for CDH1 germline mutation: Is it warranted in routine clinical practice?

32. Challenges with colorectal cancer staging: results of an international study.

33. Inflammatory bowel disease- and Barrett's esophagus-associated neoplasia: the old, the new, and the persistent struggles.

34. Excision recommended in high-risk patients: Revisiting the diagnosis of papilloma on core biopsy in the context of patient risk.

35. Hit or a miss: Concordance between histopathologic-endoscopic findings in gastric mucosal biopsies.

36. Apoptotic colopathy: a pragmatic approach to diagnosis.

37. Immune checkpoint inhibitor-induced gastrointestinal and hepatic injury: pathologists' perspective.

38. Should we excise? Are there any clinical or histologic features that predict upgrade in papillomas, incidental or non-incidental?

39. Russell Bodies and Russell Body Inflammatory Polyp in the Colorectum: A Review of Clinicopathologic Features.

40. Neural and neurogenic tumours of the gastroenteropancreaticobiliary tract.

41. Interobserver Agreement in the Diagnosis of Inflammatory Bowel Disease-Associated Neoplasia in China in Comparison to Subspecialized American Gastrointestinal Pathologists.

42. RNA-seq implicates deregulation of the immune system in the pathogenesis of diverticulitis.

43. Gastric Angiolipoma: A Rare Entity.

44. Trends in extramural consultation: comparison between subspecialized and general surgical pathology service models.

45. Frozen Section Interpretation of Pancreatic Margins: Subspecialized Gastrointestinal Pathologists Versus General Pathologists.

46. Spectrum of Gastric Histopathologies in Severely Obese American Patients Undergoing Sleeve Gastrectomy.

47. Increasing diagnostic accuracy to grade dysplasia in Barrett's esophagus using an immunohistochemical panel for CDX2, p120ctn, c-Myc and Jagged1.

48. Mammary Hibernoma: A Rare Entity.

49. Inflammatory Fibroid Polyp of the Ileocecal Valve: Case Report, Review, and Recent Advances.

50. Pathologic-radiologic correlation in evaluation of retroareolar margin in nipple-sparing mastectomy.